Isabelle Sbille, UCB Biopharma SRL - Qepler Summits And Conferences

Isabelle Sbille

Associate director- Material Safety Expert (E&L)
UCB Biopharma SRL
With a unique combination of expertise in biology and chemistry, UCB is a global biopharma focusing on severe diseases in two therapeutic areas – CNS and Immunology.

Related Sessions:

3rd Annual Extractables &
Leachables Summit 2023

Get the latest updates in regulation, analytical testing, risk & safety assessment, biocompatibility.
  • 11 Oct 2023
  • Virtual,
  • Pharma
Day 2: Thursday, 12 October 2023
CASE STUDY: Challenge for Industry with new USP665/1665
  • Risk Assessment Methodology (Upstream, Downstream process)
  • Analysis of regulation and Requirements
  • Key Challenge and experience from USP 1665
View Details